Completed

Family Health After Predictive Huntington Disease Testing

0 criteria met from your profileSee at a glance how your profile meets each eligibility criteria.
What is being collected

Data Collection

Who is being recruted

Basal Ganglia Diseases+12

+ Mental Disorders

+ Brain Diseases

See all eligibility criteria
How is the trial designed

Observational
Study Start: September 2001
See protocol details

Summary

Principal SponsorNational Institute of Nursing Research (NINR)
Last updated: January 14, 2026
Sourced from a government-validated database.Claim as a partner

Study start date: September 1, 2001

Actual date on which the first participant was enrolled.

This is an observational study with three phases. In Phase 1, focus groups consisting of family members of persons with HD Gene mutation will be conducted and data collected to be analyzed through content analysis to identify salient themes and key issues. In Phase 2, a survey instrument will be developed and field-tested in order to describe the health care needs, management strategies, and needs for health and social services of relative/significant others of asymptomatic and symptomatic persons with the mutation in the gene for HD. In Phase 3, the survey will be distributed to family members of asymptomatic and symptomatic persons with mutation in the gene for HD and frequencies and comparisons of survey responses according to respondent characteristics will be reported.

Official TitleFamily Health After Predictive Huntington Disease Testing 
Principal SponsorNational Institute of Nursing Research (NINR)
Last updated: January 14, 2026
Sourced from a government-validated database.Claim as a partner

Protocol

This section provides details of the study plan, including how the study is designed and what the study is measuring.
Design Details

422 patients to be enrolled

Total number of participants that the clinical trial aims to recruit.

Eligibility

Researchers look for people who fit a certain description, called eligibility criteria: person's general health condition or prior treatments.
Conditions
Criteria

Any sex

Biological sex of participants that are eligible to enroll.

Healthy volunteers not allowed

If individuals who are healthy and do not have the condition being studied can participate.

Conditions

Pathology

Basal Ganglia DiseasesMental DisordersBrain DiseasesCentral Nervous System DiseasesChoreaCognition DisordersDementiaHuntington DiseaseMovement DisordersNervous System DiseasesNeurodegenerative DiseasesNeurocognitive DisordersHeredodegenerative Disorders, Nervous SystemDyskinesiasGenetic Diseases, Inborn

Criteria

* Family members of asymptomatic and symptomatic persons with mutation in the gene for Huntington Disease

Study Plan

Find out more about all the medication administered in this study, their detailed description and what they involve.
Study Objectives

Study Objectives

Primary Objectives

Secondary Objectives

Study Centers

These are the hospitals, clinics, or research facilities where the trial is being conducted. You can find the location closest to you and its status.

This study has 1 location

Suspended

The University of Iowa College of Nursing

Iowa City, United StatesSee the location
CompletedOne Study Center